Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caelyx in Metastatic Breast Cancer
NCT00005980Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 2000
- Primary completion
- Jul 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 9
01
Overview
A Phase 2 trial of doxorubicin in breast cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Apr 2000; status: completed.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00005980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005980.